Levosimendan: Situación actual y futuro
María del Carmen Martín Lorenzo +2 more
openalex +2 more sources
Inhibition of Mettl3 alleviates low-dose cisplatin-induced renal fibrosis and enhances the chemotherapeutic efficacy in mouse models of cancer. [PDF]
Xie Y, Li H, Pan J, Li Y, Zhang D.
europepmc +1 more source
Effect of Levosimendan Use on All-Cause Mortality in Out-of-Hospital Cardiac Arrest Survivors After Extracorporeal Cardiopulmonary Resuscitation. [PDF]
Chen DL, Lin YK, Wang GJ, Chang KC.
europepmc +1 more source
Effect of levosimendan on erythrocyte deformability during myocardial ischaemia-reperfusion injury
Mustafa Arslan +6 more
openalex +2 more sources
Pre-Procedural Use of Levosimendan in High-Risk ACS-PCI Patients with Reduced Left Ventricle Ejection Fraction-Short-Term Outcomes. [PDF]
Turkiewicz K +11 more
europepmc +1 more source
Post-acute Myocardial Infarction Complication: A Ventricular Septal Defect. [PDF]
Rodrigues Barbosa B +4 more
europepmc +1 more source
Non-mechanical haemodynamic support in acute pulmonary thromboembolism: a scoping review. [PDF]
Body W +5 more
europepmc +1 more source
Levosimendan alleviates myocardial ischemia-reperfusion injury by regulating mitochondrial autophagy through cGAS-STING signaling pathway. [PDF]
Shi F, Bao H, Meng F, Pang Y.
europepmc +1 more source

